Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_assertion type Assertion NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_head.
- NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_assertion description "[Among the 14 adenocarcinomas examined, two (14%) showed more than twice the level of ROS1 expression in tumor tissue than was observed in matched normal tissue and statistically significant differences in the ROS1 promoter methylation level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_provenance.
- NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_assertion evidence source_evidence_literature NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_provenance.
- NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_assertion SIO_000772 22915320 NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_provenance.
- NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_assertion wasDerivedFrom befree-20140225 NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_provenance.
- NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_assertion wasGeneratedBy ECO_0000203 NP465625.RAEyI-QT-2GhJo-WH44i0TwpSqnSvG_hMZ3GjynsmDBZM130_provenance.